Non-small Cell Lung Cancer Drugs Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-small Cell Lung Cancer Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Biologics
1.2.3 Small Molecule Targeted Therapy
1.2.4 Chemotherapy
1.2.5 Other
1.3 Market by Application
1.3.1 Global Non-small Cell Lung Cancer Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Lung Adenocarcinoma
1.3.3 Squamous Cell Lung Carcinoma
1.3.4 Large-cell Lung Carcinoma
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Non-small Cell Lung Cancer Drugs Market Perspective (2017-2028)
2.2 Non-small Cell Lung Cancer Drugs Growth Trends by Region
2.2.1 Non-small Cell Lung Cancer Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Non-small Cell Lung Cancer Drugs Historic Market Size by Region (2017-2022)
2.2.3 Non-small Cell Lung Cancer Drugs Forecasted Market Size by Region (2023-2028)
2.3 Non-small Cell Lung Cancer Drugs Market Dynamics
2.3.1 Non-small Cell Lung Cancer Drugs Industry Trends
2.3.2 Non-small Cell Lung Cancer Drugs Market Drivers
2.3.3 Non-small Cell Lung Cancer Drugs Market Challenges
2.3.4 Non-small Cell Lung Cancer Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-small Cell Lung Cancer Drugs Players by Revenue
3.1.1 Global Top Non-small Cell Lung Cancer Drugs Players by Revenue (2017-2022)
3.1.2 Global Non-small Cell Lung Cancer Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Non-small Cell Lung Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Non-small Cell Lung Cancer Drugs Revenue
3.4 Global Non-small Cell Lung Cancer Drugs Market Concentration Ratio
3.4.1 Global Non-small Cell Lung Cancer Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-small Cell Lung Cancer Drugs Revenue in 2021
3.5 Non-small Cell Lung Cancer Drugs Key Players Head office and Area Served
3.6 Key Players Non-small Cell Lung Cancer Drugs Product Solution and Service
3.7 Date of Enter into Non-small Cell Lung Cancer Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-small Cell Lung Cancer Drugs Breakdown Data by Type
4.1 Global Non-small Cell Lung Cancer Drugs Historic Market Size by Type (2017-2022)
4.2 Global Non-small Cell Lung Cancer Drugs Forecasted Market Size by Type (2023-2028)
5 Non-small Cell Lung Cancer Drugs Breakdown Data by Application
5.1 Global Non-small Cell Lung Cancer Drugs Historic Market Size by Application (2017-2022)
5.2 Global Non-small Cell Lung Cancer Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Non-small Cell Lung Cancer Drugs Market Size (2017-2028)
6.2 North America Non-small Cell Lung Cancer Drugs Market Size by Type
6.2.1 North America Non-small Cell Lung Cancer Drugs Market Size by Type (2017-2022)
6.2.2 North America Non-small Cell Lung Cancer Drugs Market Size by Type (2023-2028)
6.2.3 North America Non-small Cell Lung Cancer Drugs Market Share by Type (2017-2028)
6.3 North America Non-small Cell Lung Cancer Drugs Market Size by Application
6.3.1 North America Non-small Cell Lung Cancer Drugs Market Size by Application (2017-2022)
6.3.2 North America Non-small Cell Lung Cancer Drugs Market Size by Application (2023-2028)
6.3.3 North America Non-small Cell Lung Cancer Drugs Market Share by Application (2017-2028)
6.4 North America Non-small Cell Lung Cancer Drugs Market Size by Country
6.4.1 North America Non-small Cell Lung Cancer Drugs Market Size by Country (2017-2022)
6.4.2 North America Non-small Cell Lung Cancer Drugs Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Non-small Cell Lung Cancer Drugs Market Size (2017-2028)
7.2 Europe Non-small Cell Lung Cancer Drugs Market Size by Type
7.2.1 Europe Non-small Cell Lung Cancer Drugs Market Size by Type (2017-2022)
7.2.2 Europe Non-small Cell Lung Cancer Drugs Market Size by Type (2023-2028)
7.2.3 Europe Non-small Cell Lung Cancer Drugs Market Share by Type (2017-2028)
7.3 Europe Non-small Cell Lung Cancer Drugs Market Size by Application
7.3.1 Europe Non-small Cell Lung Cancer Drugs Market Size by Application (2017-2022)
7.3.2 Europe Non-small Cell Lung Cancer Drugs Market Size by Application (2023-2028)
7.3.3 Europe Non-small Cell Lung Cancer Drugs Market Share by Application (2017-2028)
7.4 Europe Non-small Cell Lung Cancer Drugs Market Size by Country
7.4.1 Europe Non-small Cell Lung Cancer Drugs Market Size by Country (2017-2022)
7.4.2 Europe Non-small Cell Lung Cancer Drugs Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Non-small Cell Lung Cancer Drugs Market Size (2017-2028)
8.2 Asia-Pacific Non-small Cell Lung Cancer Drugs Market Size by Type
8.2.1 Asia-Pacific Non-small Cell Lung Cancer Drugs Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Non-small Cell Lung Cancer Drugs Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Non-small Cell Lung Cancer Drugs Market Share by Type (2017-2028)
8.3 Asia-Pacific Non-small Cell Lung Cancer Drugs Market Size by Application
8.3.1 Asia-Pacific Non-small Cell Lung Cancer Drugs Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Non-small Cell Lung Cancer Drugs Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Non-small Cell Lung Cancer Drugs Market Share by Application (2017-2028)
8.4 Asia-Pacific Non-small Cell Lung Cancer Drugs Market Size by Region
8.4.1 Asia-Pacific Non-small Cell Lung Cancer Drugs Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Non-small Cell Lung Cancer Drugs Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Non-small Cell Lung Cancer Drugs Market Size (2017-2028)
9.2 Latin America Non-small Cell Lung Cancer Drugs Market Size by Type
9.2.1 Latin America Non-small Cell Lung Cancer Drugs Market Size by Type (2017-2022)
9.2.2 Latin America Non-small Cell Lung Cancer Drugs Market Size by Type (2023-2028)
9.2.3 Latin America Non-small Cell Lung Cancer Drugs Market Share by Type (2017-2028)
9.3 Latin America Non-small Cell Lung Cancer Drugs Market Size by Application
9.3.1 Latin America Non-small Cell Lung Cancer Drugs Market Size by Application (2017-2022)
9.3.2 Latin America Non-small Cell Lung Cancer Drugs Market Size by Application (2023-2028)
9.3.3 Latin America Non-small Cell Lung Cancer Drugs Market Share by Application (2017-2028)
9.4 Latin America Non-small Cell Lung Cancer Drugs Market Size by Country
9.4.1 Latin America Non-small Cell Lung Cancer Drugs Market Size by Country (2017-2022)
9.4.2 Latin America Non-small Cell Lung Cancer Drugs Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size (2017-2028)
10.2 Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size by Type
10.2.1 Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Non-small Cell Lung Cancer Drugs Market Share by Type (2017-2028)
10.3 Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size by Application
10.3.1 Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Non-small Cell Lung Cancer Drugs Market Share by Application (2017-2028)
10.4 Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size by Country
10.4.1 Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Non-small Cell Lung Cancer Drugs Introduction
11.1.4 AstraZeneca Revenue in Non-small Cell Lung Cancer Drugs Business (2017-2022)
11.1.5 AstraZeneca Recent Developments
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Company Details
11.2.2 Bristol-Myers Squibb Company Business Overview
11.2.3 Bristol-Myers Squibb Company Non-small Cell Lung Cancer Drugs Introduction
11.2.4 Bristol-Myers Squibb Company Revenue in Non-small Cell Lung Cancer Drugs Business (2017-2022)
11.2.5 Bristol-Myers Squibb Company Recent Developments
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Company Details
11.3.2 Eli Lilly and Company Business Overview
11.3.3 Eli Lilly and Company Non-small Cell Lung Cancer Drugs Introduction
11.3.4 Eli Lilly and Company Revenue in Non-small Cell Lung Cancer Drugs Business (2017-2022)
11.3.5 Eli Lilly and Company Recent Developments
11.4 F. Hoffmann-La Roche Ltd
11.4.1 F. Hoffmann-La Roche Ltd Company Details
11.4.2 F. Hoffmann-La Roche Ltd Business Overview
11.4.3 F. Hoffmann-La Roche Ltd Non-small Cell Lung Cancer Drugs Introduction
11.4.4 F. Hoffmann-La Roche Ltd Revenue in Non-small Cell Lung Cancer Drugs Business (2017-2022)
11.4.5 F. Hoffmann-La Roche Ltd Recent Developments
11.5 Merck & Co., Inc.
11.5.1 Merck & Co., Inc. Company Details
11.5.2 Merck & Co., Inc. Business Overview
11.5.3 Merck & Co., Inc. Non-small Cell Lung Cancer Drugs Introduction
11.5.4 Merck & Co., Inc. Revenue in Non-small Cell Lung Cancer Drugs Business (2017-2022)
11.5.5 Merck & Co., Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Non-small Cell Lung Cancer Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Biologics
Table 3. Key Players of Small Molecule Targeted Therapy
Table 4. Key Players of Chemotherapy
Table 5. Key Players of Other
Table 6. Global Non-small Cell Lung Cancer Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Non-small Cell Lung Cancer Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Non-small Cell Lung Cancer Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Non-small Cell Lung Cancer Drugs Market Share by Region (2017-2022)
Table 10. Global Non-small Cell Lung Cancer Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Non-small Cell Lung Cancer Drugs Market Share by Region (2023-2028)
Table 12. Non-small Cell Lung Cancer Drugs Market Trends
Table 13. Non-small Cell Lung Cancer Drugs Market Drivers
Table 14. Non-small Cell Lung Cancer Drugs Market Challenges
Table 15. Non-small Cell Lung Cancer Drugs Market Restraints
Table 16. Global Non-small Cell Lung Cancer Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Non-small Cell Lung Cancer Drugs Revenue Share by Players (2017-2022)
Table 18. Global Top Non-small Cell Lung Cancer Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-small Cell Lung Cancer Drugs as of 2021)
Table 19. Ranking of Global Top Non-small Cell Lung Cancer Drugs Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Non-small Cell Lung Cancer Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Non-small Cell Lung Cancer Drugs Product Solution and Service
Table 23. Date of Enter into Non-small Cell Lung Cancer Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Non-small Cell Lung Cancer Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Non-small Cell Lung Cancer Drugs Revenue Market Share by Type (2017-2022)
Table 27. Global Non-small Cell Lung Cancer Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Non-small Cell Lung Cancer Drugs Revenue Market Share by Type (2023-2028)
Table 29. Global Non-small Cell Lung Cancer Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Non-small Cell Lung Cancer Drugs Revenue Share by Application (2017-2022)
Table 31. Global Non-small Cell Lung Cancer Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Non-small Cell Lung Cancer Drugs Revenue Share by Application (2023-2028)
Table 33. North America Non-small Cell Lung Cancer Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Non-small Cell Lung Cancer Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Non-small Cell Lung Cancer Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Non-small Cell Lung Cancer Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Non-small Cell Lung Cancer Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Non-small Cell Lung Cancer Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Non-small Cell Lung Cancer Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Non-small Cell Lung Cancer Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Non-small Cell Lung Cancer Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Non-small Cell Lung Cancer Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Non-small Cell Lung Cancer Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Non-small Cell Lung Cancer Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Non-small Cell Lung Cancer Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Non-small Cell Lung Cancer Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Non-small Cell Lung Cancer Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Non-small Cell Lung Cancer Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Non-small Cell Lung Cancer Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Non-small Cell Lung Cancer Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Non-small Cell Lung Cancer Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Non-small Cell Lung Cancer Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Non-small Cell Lung Cancer Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Non-small Cell Lung Cancer Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Non-small Cell Lung Cancer Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Non-small Cell Lung Cancer Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Non-small Cell Lung Cancer Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Non-small Cell Lung Cancer Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Non-small Cell Lung Cancer Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Non-small Cell Lung Cancer Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Non-small Cell Lung Cancer Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Non-small Cell Lung Cancer Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 63. AstraZeneca Company Details
Table 64. AstraZeneca Business Overview
Table 65. AstraZeneca Non-small Cell Lung Cancer Drugs Product
Table 66. AstraZeneca Revenue in Non-small Cell Lung Cancer Drugs Business (2017-2022) & (US$ Million)
Table 67. AstraZeneca Recent Developments
Table 68. Bristol-Myers Squibb Company Company Details
Table 69. Bristol-Myers Squibb Company Business Overview
Table 70. Bristol-Myers Squibb Company Non-small Cell Lung Cancer Drugs Product
Table 71. Bristol-Myers Squibb Company Revenue in Non-small Cell Lung Cancer Drugs Business (2017-2022) & (US$ Million)
Table 72. Bristol-Myers Squibb Company Recent Developments
Table 73. Eli Lilly and Company Company Details
Table 74. Eli Lilly and Company Business Overview
Table 75. Eli Lilly and Company Non-small Cell Lung Cancer Drugs Product
Table 76. Eli Lilly and Company Revenue in Non-small Cell Lung Cancer Drugs Business (2017-2022) & (US$ Million)
Table 77. Eli Lilly and Company Recent Developments
Table 78. F. Hoffmann-La Roche Ltd Company Details
Table 79. F. Hoffmann-La Roche Ltd Business Overview
Table 80. F. Hoffmann-La Roche Ltd Non-small Cell Lung Cancer Drugs Product
Table 81. F. Hoffmann-La Roche Ltd Revenue in Non-small Cell Lung Cancer Drugs Business (2017-2022) & (US$ Million)
Table 82. F. Hoffmann-La Roche Ltd Recent Developments
Table 83. Merck & Co., Inc. Company Details
Table 84. Merck & Co., Inc. Business Overview
Table 85. Merck & Co., Inc. Non-small Cell Lung Cancer Drugs Product
Table 86. Merck & Co., Inc. Revenue in Non-small Cell Lung Cancer Drugs Business (2017-2022) & (US$ Million)
Table 87. Merck & Co., Inc. Recent Developments
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-small Cell Lung Cancer Drugs Market Share by Type: 2021 VS 2028
Figure 2. Biologics Features
Figure 3. Small Molecule Targeted Therapy Features
Figure 4. Chemotherapy Features
Figure 5. Other Features
Figure 6. Global Non-small Cell Lung Cancer Drugs Market Share by Application: 2021 VS 2028
Figure 7. Lung Adenocarcinoma Case Studies
Figure 8. Squamous Cell Lung Carcinoma Case Studies
Figure 9. Large-cell Lung Carcinoma Case Studies
Figure 10. Non-small Cell Lung Cancer Drugs Report Years Considered
Figure 11. Global Non-small Cell Lung Cancer Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Non-small Cell Lung Cancer Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Non-small Cell Lung Cancer Drugs Market Share by Region: 2021 VS 2028
Figure 14. Global Non-small Cell Lung Cancer Drugs Market Share by Players in 2021
Figure 15. Global Top Non-small Cell Lung Cancer Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-small Cell Lung Cancer Drugs as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Non-small Cell Lung Cancer Drugs Revenue in 2021
Figure 17. North America Non-small Cell Lung Cancer Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Non-small Cell Lung Cancer Drugs Market Size Market Share by Type (2017-2028)
Figure 19. North America Non-small Cell Lung Cancer Drugs Market Size Market Share by Application (2017-2028)
Figure 20. North America Non-small Cell Lung Cancer Drugs Market Size Share by Country (2017-2028)
Figure 21. United States Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Non-small Cell Lung Cancer Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Non-small Cell Lung Cancer Drugs Market Size Market Share by Type (2017-2028)
Figure 25. Europe Non-small Cell Lung Cancer Drugs Market Size Market Share by Application (2017-2028)
Figure 26. Europe Non-small Cell Lung Cancer Drugs Market Size Share by Country (2017-2028)
Figure 27. Germany Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Non-small Cell Lung Cancer Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Non-small Cell Lung Cancer Drugs Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Non-small Cell Lung Cancer Drugs Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Non-small Cell Lung Cancer Drugs Market Size Share by Region (2017-2028)
Figure 37. China Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Non-small Cell Lung Cancer Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Non-small Cell Lung Cancer Drugs Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Non-small Cell Lung Cancer Drugs Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Non-small Cell Lung Cancer Drugs Market Size Share by Country (2017-2028)
Figure 47. Mexico Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Non-small Cell Lung Cancer Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Non-small Cell Lung Cancer Drugs Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Non-small Cell Lung Cancer Drugs Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Non-small Cell Lung Cancer Drugs Market Size Share by Country (2017-2028)
Figure 53. Turkey Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Non-small Cell Lung Cancer Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. AstraZeneca Revenue Growth Rate in Non-small Cell Lung Cancer Drugs Business (2017-2022)
Figure 57. Bristol-Myers Squibb Company Revenue Growth Rate in Non-small Cell Lung Cancer Drugs Business (2017-2022)
Figure 58. Eli Lilly and Company Revenue Growth Rate in Non-small Cell Lung Cancer Drugs Business (2017-2022)
Figure 59. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Non-small Cell Lung Cancer Drugs Business (2017-2022)
Figure 60. Merck & Co., Inc. Revenue Growth Rate in Non-small Cell Lung Cancer Drugs Business (2017-2022)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Industry Market Size
